This website is intended for healthcare professionals outside of the US only.
Cookie Statement
Cookie List
A cookie is a small piece of data (text file) that a website – when visited by a user – asks your browser to store on your device in order to remember information about you, such as your language preference or login information. Those cookies are set by us and called first-party cookies. We also use third-party cookies – which are cookies from a domain different than the domain of the website you are visiting – for our advertising and marketing efforts. More specifically, we use cookies and other tracking technologies for the following purposes:
Performance Cookies
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
| Cookie Subgroup | Cookies | Cookies used |
|---|---|---|
| amicuspompeexchange.com | isHCP | First Party |
Strictly Necessary Cookies
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.
| Cookie Subgroup | Cookies | Cookies used |
|---|---|---|
| amicuspompeexchange.com | OptanonAlertBoxClosed , OptanonConsent | First Party |
This website is intended for healthcare professionals outside of the US only.
Adverse events should be reported
▼This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.
Adverse events should be reported. For the UK (including Northern Ireland), reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Amicus on 08082346864 or via email to drugsafety@amicusrx.com
Copyright © 2026 Amicus Therapeutics, Inc. All rights reserved
PP-AT-ABP-0009-1025-2 | January 2026